Quantum Labs
Español (México)
PT-141 10 mgPack de 10 viales6 en stockAhorra 25%
peptideintermediate6 en stock

PT-141 10 mg

Agonista de melanocortina bremelanotida

PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.

Dosis
10mg / vial
Forma
Polvo liofilizado
Pack
Pack de 10 viales

Solo para uso en investigación. Este compuesto se vende estrictamente para investigación in vitro y fines de laboratorio, y no está destinado al consumo humano ni a uso terapéutico. Al comprar, usted confirma que es un investigador calificado y acepta nuestro aviso legal completo.

$2,636 MXN
Ahorra 25%
Pack de 10 viales
Antes $3,514 MXN
Se vende en pack de 10 viales

Solo quedan 6 packs

🧪Verificado en laboratorio
✓Analizado por terceros
⚡Envío internacional rápido
🔒Pago con tarjeta seguro
Descripción

Agonista sintético de receptores de melanocortina, estudiado por sus efectos sobre las vías neurales asociadas con la respuesta sexual en aplicaciones de investigación.

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.

Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

Mecanismo

La investigación sugiere un agonismo principal de MC4R, con efectos sobre el sistema nervioso central en marcadores neuroquímicos en sujetos de estudio.

Informe de laboratorio

Verificado por HPLC frente a una especificación de pureza ≥99 %. Analizado de forma independiente por laboratorios acreditados de terceros.

FAQ para investigadores

PT-141 — preguntas frecuentes

What is PT-141?

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.

Is PT-141 legal in Australia?

PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.

What receptors does PT-141 target?

PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.

What is bremelanotide?

Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.

What is the typical PT-141 research dosage?

Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

Lecturas relacionadas

Guías relacionadas con PT-141

Compuestos relacionados

Los investigadores también exploran